FDA's DTC Survey Tweaked At PhRMA's Suggestion
This article was originally published in The Pink Sheet Daily
Executive Summary
Study will consider how different formats for communicating quantitative efficacy could affect consumers' understanding of print and TV ads.
You may also be interested in...
DTC Ads To Be Studied By FDA With Eye On Efficacy Presentations
While mandated pie charts might be one result of the research, the agency’s study also could show drug marketers how to define and describe “high” and “low” efficacy.
Opening Product Labeling To Broader CE Data Is Proposed In Senate Bill
Drug product labels could contain an array of comparative effectiveness data beyond well-controlled clinical trials, if Sens. Jack Reed, D-R.I., and Barbara Mikulski, D-Md., get their way
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.